Global Extended-release Medication Market Growth (Status and Outlook) 2026-2032
The global Extended-release Medication market size is predicted to grow from US$ 41340 million in 2025 to US$ 65110 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.
Extended-release Medication refers to pharmaceutical drugs designed to release their active ingredients gradually over an extended period within the body. This controlled-release mechanism allows for a more stable and prolonged therapeutic effect, reducing the need for frequent dosing and minimizing potential side effects. Extended-release medications are commonly used for treating chronic conditions like hypertension, diabetes, and pain management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Extended-release Medication Industry Forecast? looks at past sales and reviews total world Extended-release Medication sales in 2025, providing a comprehensive analysis by region and market sector of projected Extended-release Medication sales for 2026 through 2032. With Extended-release Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extended-release Medication industry.
This Insight Report provides a comprehensive analysis of the global Extended-release Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Extended-release Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Extended-release Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extended-release Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extended-release Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Extended-release Medication market by product type, application, key players and key regions and countries.
Segmentation by Type:
Extended-release Medication refers to pharmaceutical drugs designed to release their active ingredients gradually over an extended period within the body. This controlled-release mechanism allows for a more stable and prolonged therapeutic effect, reducing the need for frequent dosing and minimizing potential side effects. Extended-release medications are commonly used for treating chronic conditions like hypertension, diabetes, and pain management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Extended-release Medication Industry Forecast? looks at past sales and reviews total world Extended-release Medication sales in 2025, providing a comprehensive analysis by region and market sector of projected Extended-release Medication sales for 2026 through 2032. With Extended-release Medication sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Extended-release Medication industry.
This Insight Report provides a comprehensive analysis of the global Extended-release Medication landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Extended-release Medication portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Extended-release Medication market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Extended-release Medication and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Extended-release Medication.
This report presents a comprehensive overview, market shares, and growth opportunities of Extended-release Medication market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Original Medication
- Generic Medication
- Hospital
- Drugstore
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Novartis
- Bayer
- Johnson & Johnson
- Takeda
- AstraZeneca
- AbbVie
- Pfizer
- Collegium Pharmaceutical, Inc
- Endo Pharmaceuticals
- Shanghai Shyndec Pharmaceutical
- Zhuhai Rundu Pharmaceutical
- China Res Double-Crane
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Extended-release Medication Market Size (2021-2032)
2.1.2 Extended-release Medication Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Extended-release Medication by Country/Region (2021, 2025 & 2032)
2.2 Extended-release Medication Segment by Type
2.2.1 Original Medication
2.2.2 Generic Medication
2.2.3 Extended-release Medication Market Size by Type
2.2.3.1 Extended-release Medication Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Extended-release Medication Market Size Market Share by Type (2021-2026)
2.3 Extended-release Medication Segment by Application
2.3.1 Hospital
2.3.2 Drugstore
2.3.3 Other
2.3.4 Extended-release Medication Market Size by Application
2.3.4.1 Extended-release Medication Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Extended-release Medication Market Size Market Share by Application (2021-2026)
3 EXTENDED-RELEASE MEDICATION MARKET SIZE BY PLAYER
3.1 Extended-release Medication Market Size Market Share by Player
3.1.1 Global Extended-release Medication Revenue by Player (2021-2026)
3.1.2 Global Extended-release Medication Revenue Market Share by Player (2021-2026)
3.2 Global Extended-release Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXTENDED-RELEASE MEDICATION BY REGION
4.1 Extended-release Medication Market Size by Region (2021-2026)
4.2 Global Extended-release Medication Annual Revenue by Country/Region (2021-2026)
4.3 Americas Extended-release Medication Market Size Growth (2021-2026)
4.4 APAC Extended-release Medication Market Size Growth (2021-2026)
4.5 Europe Extended-release Medication Market Size Growth (2021-2026)
4.6 Middle East & Africa Extended-release Medication Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Extended-release Medication Market Size by Country (2021-2026)
5.2 Americas Extended-release Medication Market Size by Type (2021-2026)
5.3 Americas Extended-release Medication Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Extended-release Medication Market Size by Region (2021-2026)
6.2 APAC Extended-release Medication Market Size by Type (2021-2026)
6.3 APAC Extended-release Medication Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Extended-release Medication Market Size by Country (2021-2026)
7.2 Europe Extended-release Medication Market Size by Type (2021-2026)
7.3 Europe Extended-release Medication Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Extended-release Medication by Region (2021-2026)
8.2 Middle East & Africa Extended-release Medication Market Size by Type (2021-2026)
8.3 Middle East & Africa Extended-release Medication Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXTENDED-RELEASE MEDICATION MARKET FORECAST
10.1 Global Extended-release Medication Forecast by Region (2027-2032)
10.1.1 Global Extended-release Medication Forecast by Region (2027-2032)
10.1.2 Americas Extended-release Medication Forecast
10.1.3 APAC Extended-release Medication Forecast
10.1.4 Europe Extended-release Medication Forecast
10.1.5 Middle East & Africa Extended-release Medication Forecast
10.2 Americas Extended-release Medication Forecast by Country (2027-2032)
10.2.1 United States Market Extended-release Medication Forecast
10.2.2 Canada Market Extended-release Medication Forecast
10.2.3 Mexico Market Extended-release Medication Forecast
10.2.4 Brazil Market Extended-release Medication Forecast
10.3 APAC Extended-release Medication Forecast by Region (2027-2032)
10.3.1 China Extended-release Medication Market Forecast
10.3.2 Japan Market Extended-release Medication Forecast
10.3.3 Korea Market Extended-release Medication Forecast
10.3.4 Southeast Asia Market Extended-release Medication Forecast
10.3.5 India Market Extended-release Medication Forecast
10.3.6 Australia Market Extended-release Medication Forecast
10.4 Europe Extended-release Medication Forecast by Country (2027-2032)
10.4.1 Germany Market Extended-release Medication Forecast
10.4.2 France Market Extended-release Medication Forecast
10.4.3 UK Market Extended-release Medication Forecast
10.4.4 Italy Market Extended-release Medication Forecast
10.4.5 Russia Market Extended-release Medication Forecast
10.5 Middle East & Africa Extended-release Medication Forecast by Region (2027-2032)
10.5.1 Egypt Market Extended-release Medication Forecast
10.5.2 South Africa Market Extended-release Medication Forecast
10.5.3 Israel Market Extended-release Medication Forecast
10.5.4 Turkey Market Extended-release Medication Forecast
10.6 Global Extended-release Medication Forecast by Type (2027-2032)
10.7 Global Extended-release Medication Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Extended-release Medication Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Extended-release Medication Product Offered
11.1.3 Sanofi Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Extended-release Medication Product Offered
11.2.3 Novartis Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Extended-release Medication Product Offered
11.3.3 Bayer Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Extended-release Medication Product Offered
11.4.3 Johnson & Johnson Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Extended-release Medication Product Offered
11.5.3 Takeda Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Extended-release Medication Product Offered
11.6.3 AstraZeneca Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 AbbVie
11.7.1 AbbVie Company Information
11.7.2 AbbVie Extended-release Medication Product Offered
11.7.3 AbbVie Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AbbVie Main Business Overview
11.7.5 AbbVie Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Extended-release Medication Product Offered
11.8.3 Pfizer Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Collegium Pharmaceutical, Inc
11.9.1 Collegium Pharmaceutical, Inc Company Information
11.9.2 Collegium Pharmaceutical, Inc Extended-release Medication Product Offered
11.9.3 Collegium Pharmaceutical, Inc Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Collegium Pharmaceutical, Inc Main Business Overview
11.9.5 Collegium Pharmaceutical, Inc Latest Developments
11.10 Endo Pharmaceuticals
11.10.1 Endo Pharmaceuticals Company Information
11.10.2 Endo Pharmaceuticals Extended-release Medication Product Offered
11.10.3 Endo Pharmaceuticals Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Endo Pharmaceuticals Main Business Overview
11.10.5 Endo Pharmaceuticals Latest Developments
11.11 Shanghai Shyndec Pharmaceutical
11.11.1 Shanghai Shyndec Pharmaceutical Company Information
11.11.2 Shanghai Shyndec Pharmaceutical Extended-release Medication Product Offered
11.11.3 Shanghai Shyndec Pharmaceutical Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shanghai Shyndec Pharmaceutical Main Business Overview
11.11.5 Shanghai Shyndec Pharmaceutical Latest Developments
11.12 Zhuhai Rundu Pharmaceutical
11.12.1 Zhuhai Rundu Pharmaceutical Company Information
11.12.2 Zhuhai Rundu Pharmaceutical Extended-release Medication Product Offered
11.12.3 Zhuhai Rundu Pharmaceutical Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Zhuhai Rundu Pharmaceutical Main Business Overview
11.12.5 Zhuhai Rundu Pharmaceutical Latest Developments
11.13 China Res Double-Crane
11.13.1 China Res Double-Crane Company Information
11.13.2 China Res Double-Crane Extended-release Medication Product Offered
11.13.3 China Res Double-Crane Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 China Res Double-Crane Main Business Overview
11.13.5 China Res Double-Crane Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Extended-release Medication Market Size (2021-2032)
2.1.2 Extended-release Medication Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Extended-release Medication by Country/Region (2021, 2025 & 2032)
2.2 Extended-release Medication Segment by Type
2.2.1 Original Medication
2.2.2 Generic Medication
2.2.3 Extended-release Medication Market Size by Type
2.2.3.1 Extended-release Medication Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Extended-release Medication Market Size Market Share by Type (2021-2026)
2.3 Extended-release Medication Segment by Application
2.3.1 Hospital
2.3.2 Drugstore
2.3.3 Other
2.3.4 Extended-release Medication Market Size by Application
2.3.4.1 Extended-release Medication Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Extended-release Medication Market Size Market Share by Application (2021-2026)
3 EXTENDED-RELEASE MEDICATION MARKET SIZE BY PLAYER
3.1 Extended-release Medication Market Size Market Share by Player
3.1.1 Global Extended-release Medication Revenue by Player (2021-2026)
3.1.2 Global Extended-release Medication Revenue Market Share by Player (2021-2026)
3.2 Global Extended-release Medication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXTENDED-RELEASE MEDICATION BY REGION
4.1 Extended-release Medication Market Size by Region (2021-2026)
4.2 Global Extended-release Medication Annual Revenue by Country/Region (2021-2026)
4.3 Americas Extended-release Medication Market Size Growth (2021-2026)
4.4 APAC Extended-release Medication Market Size Growth (2021-2026)
4.5 Europe Extended-release Medication Market Size Growth (2021-2026)
4.6 Middle East & Africa Extended-release Medication Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Extended-release Medication Market Size by Country (2021-2026)
5.2 Americas Extended-release Medication Market Size by Type (2021-2026)
5.3 Americas Extended-release Medication Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Extended-release Medication Market Size by Region (2021-2026)
6.2 APAC Extended-release Medication Market Size by Type (2021-2026)
6.3 APAC Extended-release Medication Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Extended-release Medication Market Size by Country (2021-2026)
7.2 Europe Extended-release Medication Market Size by Type (2021-2026)
7.3 Europe Extended-release Medication Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Extended-release Medication by Region (2021-2026)
8.2 Middle East & Africa Extended-release Medication Market Size by Type (2021-2026)
8.3 Middle East & Africa Extended-release Medication Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXTENDED-RELEASE MEDICATION MARKET FORECAST
10.1 Global Extended-release Medication Forecast by Region (2027-2032)
10.1.1 Global Extended-release Medication Forecast by Region (2027-2032)
10.1.2 Americas Extended-release Medication Forecast
10.1.3 APAC Extended-release Medication Forecast
10.1.4 Europe Extended-release Medication Forecast
10.1.5 Middle East & Africa Extended-release Medication Forecast
10.2 Americas Extended-release Medication Forecast by Country (2027-2032)
10.2.1 United States Market Extended-release Medication Forecast
10.2.2 Canada Market Extended-release Medication Forecast
10.2.3 Mexico Market Extended-release Medication Forecast
10.2.4 Brazil Market Extended-release Medication Forecast
10.3 APAC Extended-release Medication Forecast by Region (2027-2032)
10.3.1 China Extended-release Medication Market Forecast
10.3.2 Japan Market Extended-release Medication Forecast
10.3.3 Korea Market Extended-release Medication Forecast
10.3.4 Southeast Asia Market Extended-release Medication Forecast
10.3.5 India Market Extended-release Medication Forecast
10.3.6 Australia Market Extended-release Medication Forecast
10.4 Europe Extended-release Medication Forecast by Country (2027-2032)
10.4.1 Germany Market Extended-release Medication Forecast
10.4.2 France Market Extended-release Medication Forecast
10.4.3 UK Market Extended-release Medication Forecast
10.4.4 Italy Market Extended-release Medication Forecast
10.4.5 Russia Market Extended-release Medication Forecast
10.5 Middle East & Africa Extended-release Medication Forecast by Region (2027-2032)
10.5.1 Egypt Market Extended-release Medication Forecast
10.5.2 South Africa Market Extended-release Medication Forecast
10.5.3 Israel Market Extended-release Medication Forecast
10.5.4 Turkey Market Extended-release Medication Forecast
10.6 Global Extended-release Medication Forecast by Type (2027-2032)
10.7 Global Extended-release Medication Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Extended-release Medication Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Extended-release Medication Product Offered
11.1.3 Sanofi Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Extended-release Medication Product Offered
11.2.3 Novartis Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bayer
11.3.1 Bayer Company Information
11.3.2 Bayer Extended-release Medication Product Offered
11.3.3 Bayer Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bayer Main Business Overview
11.3.5 Bayer Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Extended-release Medication Product Offered
11.4.3 Johnson & Johnson Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Extended-release Medication Product Offered
11.5.3 Takeda Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Takeda Main Business Overview
11.5.5 Takeda Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Extended-release Medication Product Offered
11.6.3 AstraZeneca Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 AbbVie
11.7.1 AbbVie Company Information
11.7.2 AbbVie Extended-release Medication Product Offered
11.7.3 AbbVie Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 AbbVie Main Business Overview
11.7.5 AbbVie Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Extended-release Medication Product Offered
11.8.3 Pfizer Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Collegium Pharmaceutical, Inc
11.9.1 Collegium Pharmaceutical, Inc Company Information
11.9.2 Collegium Pharmaceutical, Inc Extended-release Medication Product Offered
11.9.3 Collegium Pharmaceutical, Inc Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Collegium Pharmaceutical, Inc Main Business Overview
11.9.5 Collegium Pharmaceutical, Inc Latest Developments
11.10 Endo Pharmaceuticals
11.10.1 Endo Pharmaceuticals Company Information
11.10.2 Endo Pharmaceuticals Extended-release Medication Product Offered
11.10.3 Endo Pharmaceuticals Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Endo Pharmaceuticals Main Business Overview
11.10.5 Endo Pharmaceuticals Latest Developments
11.11 Shanghai Shyndec Pharmaceutical
11.11.1 Shanghai Shyndec Pharmaceutical Company Information
11.11.2 Shanghai Shyndec Pharmaceutical Extended-release Medication Product Offered
11.11.3 Shanghai Shyndec Pharmaceutical Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Shanghai Shyndec Pharmaceutical Main Business Overview
11.11.5 Shanghai Shyndec Pharmaceutical Latest Developments
11.12 Zhuhai Rundu Pharmaceutical
11.12.1 Zhuhai Rundu Pharmaceutical Company Information
11.12.2 Zhuhai Rundu Pharmaceutical Extended-release Medication Product Offered
11.12.3 Zhuhai Rundu Pharmaceutical Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Zhuhai Rundu Pharmaceutical Main Business Overview
11.12.5 Zhuhai Rundu Pharmaceutical Latest Developments
11.13 China Res Double-Crane
11.13.1 China Res Double-Crane Company Information
11.13.2 China Res Double-Crane Extended-release Medication Product Offered
11.13.3 China Res Double-Crane Extended-release Medication Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 China Res Double-Crane Main Business Overview
11.13.5 China Res Double-Crane Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Extended-release Medication Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Extended-release Medication Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Medication
Table 4. Major Players of Generic Medication
Table 5. Extended-release Medication Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Extended-release Medication Market Size Market Share by Type (2021-2026)
Table 8. Extended-release Medication Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Extended-release Medication Market Size Market Share by Application (2021-2026)
Table 11. Global Extended-release Medication Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Extended-release Medication Revenue Market Share by Player (2021-2026)
Table 13. Extended-release Medication Key Players Head office and Products Offered
Table 14. Extended-release Medication Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Extended-release Medication Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Extended-release Medication Market Size Market Share by Region (2021-2026)
Table 19. Global Extended-release Medication Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Extended-release Medication Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Extended-release Medication Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Extended-release Medication Market Size Market Share by Country (2021-2026)
Table 23. Americas Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Extended-release Medication Market Size Market Share by Type (2021-2026)
Table 25. Americas Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Extended-release Medication Market Size Market Share by Application (2021-2026)
Table 27. APAC Extended-release Medication Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Extended-release Medication Market Size Market Share by Region (2021-2026)
Table 29. APAC Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Extended-release Medication Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Extended-release Medication Market Size Market Share by Country (2021-2026)
Table 33. Europe Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Extended-release Medication Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Extended-release Medication
Table 39. Key Market Challenges & Risks of Extended-release Medication
Table 40. Key Industry Trends of Extended-release Medication
Table 41. Global Extended-release Medication Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Extended-release Medication Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Extended-release Medication Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Extended-release Medication Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Sanofi Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 46. Sanofi Extended-release Medication Product Offered
Table 47. Sanofi Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Sanofi Main Business
Table 49. Sanofi Latest Developments
Table 50. Novartis Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 51. Novartis Extended-release Medication Product Offered
Table 52. Novartis Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Bayer Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 56. Bayer Extended-release Medication Product Offered
Table 57. Bayer Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bayer Main Business
Table 59. Bayer Latest Developments
Table 60. Johnson & Johnson Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 61. Johnson & Johnson Extended-release Medication Product Offered
Table 62. Johnson & Johnson Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Latest Developments
Table 65. Takeda Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 66. Takeda Extended-release Medication Product Offered
Table 67. Takeda Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Takeda Main Business
Table 69. Takeda Latest Developments
Table 70. AstraZeneca Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 71. AstraZeneca Extended-release Medication Product Offered
Table 72. AstraZeneca Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Latest Developments
Table 75. AbbVie Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 76. AbbVie Extended-release Medication Product Offered
Table 77. AbbVie Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. AbbVie Main Business
Table 79. AbbVie Latest Developments
Table 80. Pfizer Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 81. Pfizer Extended-release Medication Product Offered
Table 82. Pfizer Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Collegium Pharmaceutical, Inc Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 86. Collegium Pharmaceutical, Inc Extended-release Medication Product Offered
Table 87. Collegium Pharmaceutical, Inc Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Collegium Pharmaceutical, Inc Main Business
Table 89. Collegium Pharmaceutical, Inc Latest Developments
Table 90. Endo Pharmaceuticals Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 91. Endo Pharmaceuticals Extended-release Medication Product Offered
Table 92. Endo Pharmaceuticals Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Endo Pharmaceuticals Main Business
Table 94. Endo Pharmaceuticals Latest Developments
Table 95. Shanghai Shyndec Pharmaceutical Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 96. Shanghai Shyndec Pharmaceutical Extended-release Medication Product Offered
Table 97. Shanghai Shyndec Pharmaceutical Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Shanghai Shyndec Pharmaceutical Main Business
Table 99. Shanghai Shyndec Pharmaceutical Latest Developments
Table 100. Zhuhai Rundu Pharmaceutical Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 101. Zhuhai Rundu Pharmaceutical Extended-release Medication Product Offered
Table 102. Zhuhai Rundu Pharmaceutical Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Zhuhai Rundu Pharmaceutical Main Business
Table 104. Zhuhai Rundu Pharmaceutical Latest Developments
Table 105. China Res Double-Crane Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 106. China Res Double-Crane Extended-release Medication Product Offered
Table 107. China Res Double-Crane Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. China Res Double-Crane Main Business
Table 109. China Res Double-Crane Latest Developments
Table 1. Extended-release Medication Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Extended-release Medication Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Original Medication
Table 4. Major Players of Generic Medication
Table 5. Extended-release Medication Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Extended-release Medication Market Size Market Share by Type (2021-2026)
Table 8. Extended-release Medication Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Extended-release Medication Market Size Market Share by Application (2021-2026)
Table 11. Global Extended-release Medication Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Extended-release Medication Revenue Market Share by Player (2021-2026)
Table 13. Extended-release Medication Key Players Head office and Products Offered
Table 14. Extended-release Medication Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Extended-release Medication Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Extended-release Medication Market Size Market Share by Region (2021-2026)
Table 19. Global Extended-release Medication Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Extended-release Medication Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Extended-release Medication Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Extended-release Medication Market Size Market Share by Country (2021-2026)
Table 23. Americas Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Extended-release Medication Market Size Market Share by Type (2021-2026)
Table 25. Americas Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Extended-release Medication Market Size Market Share by Application (2021-2026)
Table 27. APAC Extended-release Medication Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Extended-release Medication Market Size Market Share by Region (2021-2026)
Table 29. APAC Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Extended-release Medication Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Extended-release Medication Market Size Market Share by Country (2021-2026)
Table 33. Europe Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Extended-release Medication Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Extended-release Medication Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Extended-release Medication Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Extended-release Medication
Table 39. Key Market Challenges & Risks of Extended-release Medication
Table 40. Key Industry Trends of Extended-release Medication
Table 41. Global Extended-release Medication Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Extended-release Medication Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Extended-release Medication Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Extended-release Medication Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Sanofi Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 46. Sanofi Extended-release Medication Product Offered
Table 47. Sanofi Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Sanofi Main Business
Table 49. Sanofi Latest Developments
Table 50. Novartis Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 51. Novartis Extended-release Medication Product Offered
Table 52. Novartis Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Bayer Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 56. Bayer Extended-release Medication Product Offered
Table 57. Bayer Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Bayer Main Business
Table 59. Bayer Latest Developments
Table 60. Johnson & Johnson Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 61. Johnson & Johnson Extended-release Medication Product Offered
Table 62. Johnson & Johnson Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Johnson & Johnson Main Business
Table 64. Johnson & Johnson Latest Developments
Table 65. Takeda Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 66. Takeda Extended-release Medication Product Offered
Table 67. Takeda Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Takeda Main Business
Table 69. Takeda Latest Developments
Table 70. AstraZeneca Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 71. AstraZeneca Extended-release Medication Product Offered
Table 72. AstraZeneca Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. AstraZeneca Main Business
Table 74. AstraZeneca Latest Developments
Table 75. AbbVie Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 76. AbbVie Extended-release Medication Product Offered
Table 77. AbbVie Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. AbbVie Main Business
Table 79. AbbVie Latest Developments
Table 80. Pfizer Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 81. Pfizer Extended-release Medication Product Offered
Table 82. Pfizer Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Collegium Pharmaceutical, Inc Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 86. Collegium Pharmaceutical, Inc Extended-release Medication Product Offered
Table 87. Collegium Pharmaceutical, Inc Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Collegium Pharmaceutical, Inc Main Business
Table 89. Collegium Pharmaceutical, Inc Latest Developments
Table 90. Endo Pharmaceuticals Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 91. Endo Pharmaceuticals Extended-release Medication Product Offered
Table 92. Endo Pharmaceuticals Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Endo Pharmaceuticals Main Business
Table 94. Endo Pharmaceuticals Latest Developments
Table 95. Shanghai Shyndec Pharmaceutical Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 96. Shanghai Shyndec Pharmaceutical Extended-release Medication Product Offered
Table 97. Shanghai Shyndec Pharmaceutical Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Shanghai Shyndec Pharmaceutical Main Business
Table 99. Shanghai Shyndec Pharmaceutical Latest Developments
Table 100. Zhuhai Rundu Pharmaceutical Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 101. Zhuhai Rundu Pharmaceutical Extended-release Medication Product Offered
Table 102. Zhuhai Rundu Pharmaceutical Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Zhuhai Rundu Pharmaceutical Main Business
Table 104. Zhuhai Rundu Pharmaceutical Latest Developments
Table 105. China Res Double-Crane Details, Company Type, Extended-release Medication Area Served and Its Competitors
Table 106. China Res Double-Crane Extended-release Medication Product Offered
Table 107. China Res Double-Crane Extended-release Medication Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. China Res Double-Crane Main Business
Table 109. China Res Double-Crane Latest Developments
LIST OF FIGURES
Figure 1. Extended-release Medication Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Extended-release Medication Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Extended-release Medication Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Extended-release Medication Sales Market Share by Country/Region (2025)
Figure 8. Extended-release Medication Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Extended-release Medication Market Size Market Share by Type in 2025
Figure 10. Extended-release Medication in Hospital
Figure 11. Global Extended-release Medication Market: Hospital (2021-2026) & ($ millions)
Figure 12. Extended-release Medication in Drugstore
Figure 13. Global Extended-release Medication Market: Drugstore (2021-2026) & ($ millions)
Figure 14. Extended-release Medication in Other
Figure 15. Global Extended-release Medication Market: Other (2021-2026) & ($ millions)
Figure 16. Global Extended-release Medication Market Size Market Share by Application in 2025
Figure 17. Global Extended-release Medication Revenue Market Share by Player in 2025
Figure 18. Global Extended-release Medication Market Size Market Share by Region (2021-2026)
Figure 19. Americas Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 20. APAC Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 21. Europe Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 23. Americas Extended-release Medication Value Market Share by Country in 2025
Figure 24. United States Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Extended-release Medication Market Size Market Share by Region in 2025
Figure 29. APAC Extended-release Medication Market Size Market Share by Type (2021-2026)
Figure 30. APAC Extended-release Medication Market Size Market Share by Application (2021-2026)
Figure 31. China Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 35. India Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Extended-release Medication Market Size Market Share by Country in 2025
Figure 38. Europe Extended-release Medication Market Size Market Share by Type (2021-2026)
Figure 39. Europe Extended-release Medication Market Size Market Share by Application (2021-2026)
Figure 40. Germany Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 41. France Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Extended-release Medication Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Extended-release Medication Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Extended-release Medication Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 54. APAC Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 55. Europe Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 57. United States Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 58. Canada Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 59. Mexico Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 60. Brazil Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 61. China Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 62. Japan Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 63. Korea Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 65. India Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 66. Australia Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 67. Germany Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 68. France Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 69. UK Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 70. Italy Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 71. Russia Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 72. Egypt Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 73. South Africa Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 74. Israel Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 75. Turkey Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 76. Global Extended-release Medication Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Extended-release Medication Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 1. Extended-release Medication Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Extended-release Medication Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Extended-release Medication Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Extended-release Medication Sales Market Share by Country/Region (2025)
Figure 8. Extended-release Medication Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Extended-release Medication Market Size Market Share by Type in 2025
Figure 10. Extended-release Medication in Hospital
Figure 11. Global Extended-release Medication Market: Hospital (2021-2026) & ($ millions)
Figure 12. Extended-release Medication in Drugstore
Figure 13. Global Extended-release Medication Market: Drugstore (2021-2026) & ($ millions)
Figure 14. Extended-release Medication in Other
Figure 15. Global Extended-release Medication Market: Other (2021-2026) & ($ millions)
Figure 16. Global Extended-release Medication Market Size Market Share by Application in 2025
Figure 17. Global Extended-release Medication Revenue Market Share by Player in 2025
Figure 18. Global Extended-release Medication Market Size Market Share by Region (2021-2026)
Figure 19. Americas Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 20. APAC Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 21. Europe Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Extended-release Medication Market Size 2021-2026 ($ millions)
Figure 23. Americas Extended-release Medication Value Market Share by Country in 2025
Figure 24. United States Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Extended-release Medication Market Size Market Share by Region in 2025
Figure 29. APAC Extended-release Medication Market Size Market Share by Type (2021-2026)
Figure 30. APAC Extended-release Medication Market Size Market Share by Application (2021-2026)
Figure 31. China Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 35. India Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Extended-release Medication Market Size Market Share by Country in 2025
Figure 38. Europe Extended-release Medication Market Size Market Share by Type (2021-2026)
Figure 39. Europe Extended-release Medication Market Size Market Share by Application (2021-2026)
Figure 40. Germany Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 41. France Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Extended-release Medication Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Extended-release Medication Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Extended-release Medication Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Extended-release Medication Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 54. APAC Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 55. Europe Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 57. United States Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 58. Canada Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 59. Mexico Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 60. Brazil Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 61. China Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 62. Japan Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 63. Korea Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 65. India Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 66. Australia Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 67. Germany Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 68. France Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 69. UK Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 70. Italy Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 71. Russia Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 72. Egypt Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 73. South Africa Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 74. Israel Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 75. Turkey Extended-release Medication Market Size 2027-2032 ($ millions)
Figure 76. Global Extended-release Medication Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Extended-release Medication Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Extended-release Medication Market Size 2027-2032 ($ millions)
